Sign in

NCT07183566Not yet recruiting

CT Volume Measurement of Hepatocellular Carcinoma

Ct Volume Measurement of Hepatocellular Carcinoma After Transarterial Chemoembolization (TACE) or Microwave Ablation (MWA)

Source: ClinicalTrials.gov · Last updated 19 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of this study is to evaluate the role of CT volumetric measurement in assessing treatment response of hepatocellular carcinoma (HCC) following trans arterial chemoembolization (TACE) or microwave ablation (MWA)

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
66 (estimated)
First submitted
12 Sept 2025
Start date
1 Oct 2025
Primary completion date
1 Oct 2027
Lead sponsor
Assiut University
NCT number
NCT07183566

What you commit to

  • Study type: Observational
  • Planned participants: 66
  • From 1 Oct 2025 to the primary completion date, 1 Oct 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with extrahepatic metastases or portal vein thrombosis.
  • Patients with severe comorbid illness that precludes participation.

Other

  • Patients with contraindications to iodinated contrast or TACE.
  • Patients refuse to provide informed consent.

Who the study is looking for

  • Adult patients (≥18 years) with a confirmed diagnosis of HCC based on AASLD or EASL criteria.
  • Patients deemed unresectable by the multidisciplinary tumor board.
  • Patients scheduled for TACE as the primary locoregional therapy.
  • Preserved liver function (Child-Pugh class A or B).
  • Adequate renal function to permit contrast-enhanced CT.

Age in the registry: 18 years to - · Sex: All

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.